These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1274 related articles for article (PubMed ID: 27377924)
41. Transanal Versus Laparoscopic Total Mesorectal Excision: A Comparative Prospective Clinical Trial from Two Centers. Zuhdy M; Elmore U; Shams N; Hegazy MAF; Roshdy S; Eldamshety O; Metwally IH; Rosati R J Laparoendosc Adv Surg Tech A; 2020 Jul; 30(7):769-776. PubMed ID: 32240035 [No Abstract] [Full Text] [Related]
42. Quality of life and functional outcomes after laparoscopic total mesorectal excision (LaTME) and transanal total mesorectal excision (taTME) for rectal cancer. an updated meta-analysis. Lauricella S; Brucchi F; Carrano FM; Cassini D; Cirocchi R; Sylla P Int J Colorectal Dis; 2024 Aug; 39(1):129. PubMed ID: 39120642 [TBL] [Abstract][Full Text] [Related]
43. Short-term Outcomes of Transanal versus Laparoscopic Total Mesorectal Excision: A Systematic Review and Meta-Analysis of Cohort Studies. Wu Z; Zhou W; Chen F; Wang W; Feng Y J Cancer; 2019; 10(2):341-354. PubMed ID: 30719128 [No Abstract] [Full Text] [Related]
44. Short Term Postoperative and Oncological Outcomes of Two-Dimensional Versus Three-Dimensional Laparoscopic Transanal Total Mesorectal Excision of Rectal Cancer. Tey HTV; Foo SMJ; Fong SS; Chong CS J Laparoendosc Adv Surg Tech A; 2020 Dec; 30(12):1350-1353. PubMed ID: 32522084 [No Abstract] [Full Text] [Related]
45. A systematic review and meta-analysis of robotic-assisted transabdominal total mesorectal excision and transanal total mesorectal excision: which approach offers optimal short-term outcomes for mid-to-low rectal adenocarcinoma? Butterworth JW; Butterworth WA; Meyer J; Giacobino C; Buchs N; Ris F; Scarpinata R Tech Coloproctol; 2021 Nov; 25(11):1183-1198. PubMed ID: 34562160 [TBL] [Abstract][Full Text] [Related]
46. Three-year outcomes of transanal total mesorectal excision versus standard laparoscopic total mesorectal excision for mid and low rectal cancer. Zeng Z; Liu Z; Luo S; Liang Z; Huang L; Ruan L; Chen J; Jie H; Liang W; Liu H; Kang L Surg Endosc; 2022 Jun; 36(6):3902-3910. PubMed ID: 34448933 [TBL] [Abstract][Full Text] [Related]
47. Comparing functional outcomes between transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LaTME) for rectal cancer: a systematic review and meta-analysis. Choy KT; Yang TWW; Prabhakaran S; Heriot A; Kong JC; Warrier SK Int J Colorectal Dis; 2021 Jun; 36(6):1163-1174. PubMed ID: 33580808 [TBL] [Abstract][Full Text] [Related]
48. Functional outcomes after resections for low rectal tumors: comparison of Transanal with laparoscopic Total Mesorectal excision. Rubinkiewicz M; Zarzycki P; Witowski J; Pisarska M; Gajewska N; Torbicz G; Nowakowski M; Major P; Budzyński A; Pędziwiatr M BMC Surg; 2019 Jul; 19(1):79. PubMed ID: 31277628 [TBL] [Abstract][Full Text] [Related]
49. Transanal total mesorectal excision: pathological results of 186 patients with mid and low rectal cancer. de Lacy FB; van Laarhoven JJEM; Pena R; Arroyave MC; Bravo R; Cuatrecasas M; Lacy AM Surg Endosc; 2018 May; 32(5):2442-2447. PubMed ID: 29101570 [TBL] [Abstract][Full Text] [Related]
50. Transanal rectal resection: an initial experience of 20 cases. Buchs NC; Nicholson GA; Yeung T; Mortensen NJ; Cunningham C; Jones OM; Guy R; Hompes R Colorectal Dis; 2016 Jan; 18(1):45-50. PubMed ID: 26639062 [TBL] [Abstract][Full Text] [Related]
51. Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review. Deijen CL; Tsai A; Koedam TW; Veltcamp Helbach M; Sietses C; Lacy AM; Bonjer HJ; Tuynman JB Tech Coloproctol; 2016 Dec; 20(12):811-824. PubMed ID: 27853973 [TBL] [Abstract][Full Text] [Related]
52. Robotic low anterior resection versus transanal total mesorectal excision in rectal cancer: A comparison of 115 cases. Perez D; Melling N; Biebl M; Reeh M; Baukloh JK; Miro J; Polonski A; Izbicki JR; Knoll B; Pratschke J; Aigner F Eur J Surg Oncol; 2018 Feb; 44(2):237-242. PubMed ID: 29249592 [TBL] [Abstract][Full Text] [Related]
53. [Network meta-analysis comparing the clinical outcomes and safety of robotic, laparoscopic, and transanal total rectal mesenteric resection for rectal cancer]. Liu Y; Shen W; Tian ZQ; Zhang YC; Tao GQ; Zhu YF; Song GD; Cao JC; Huang YK; Song C Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):475-484. PubMed ID: 37217356 [No Abstract] [Full Text] [Related]
54. Short- and mid-term outcomes of transanal versus laparoscopic total mesorectal excision for low rectal cancer: a meta-analysis. Ren J; Luo H; Liu S; Wang B; Wu F Ann Surg Treat Res; 2021 Feb; 100(2):86-99. PubMed ID: 33585353 [TBL] [Abstract][Full Text] [Related]
55. Comparison of Short-Term Clinical and Pathological Outcomes after Transanal versus Laparoscopic Total Mesorectal Excision for Low Anterior Rectal Resection Due to Rectal Cancer: A Systematic Review with Meta-Analysis. Rubinkiewicz M; Czerwińska A; Zarzycki P; Małczak P; Nowakowski M; Major P; Budzyński A; Pędziwiatr M J Clin Med; 2018 Nov; 7(11):. PubMed ID: 30463197 [TBL] [Abstract][Full Text] [Related]
56. Long-term oncological outcomes of transanal versus laparoscopic total mesorectal excision for mid-low rectal cancer: a retrospective analysis of 2502 patients. Li Z; Liu H; Luo S; Hou Y; Zhou Y; Zheng X; Zhang X; Huang L; Zeng Z; Kang L Int J Surg; 2024 Mar; 110(3):1611-1619. PubMed ID: 38091943 [TBL] [Abstract][Full Text] [Related]
57. Transanal total mesorectal excision for rectal cancer: early outcomes in 50 consecutive patients. Burke JP; Martin-Perez B; Khan A; Nassif G; de Beche-Adams T; Larach SW; Albert MR; Atallah S Colorectal Dis; 2016 Jun; 18(6):570-7. PubMed ID: 26749148 [TBL] [Abstract][Full Text] [Related]
58. [Current status of research on short-term urogenital function after transanal total mesorectal excision and laparoscopic total mesorectal excision]. Li HZ; Gao JL; Yao HW Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):552-557. PubMed ID: 35754222 [TBL] [Abstract][Full Text] [Related]
59. Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve. D'Andrea AP; McLemore EC; Bonaccorso A; Cuevas JM; Basam M; Tsay AT; Bhasin D; Attaluri V; Sylla P Surg Endosc; 2020 Sep; 34(9):4101-4109. PubMed ID: 31602515 [TBL] [Abstract][Full Text] [Related]
60. Transanal versus conventional total mesorectal excision for rectal cancer using the IDEAL framework for implementation. Robertson RL; Karimuddin A; Phang T; Raval M; Brown C BJS Open; 2021 Mar; 5(2):. PubMed ID: 33889949 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]